BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 32132024)

  • 1. Cigarette Smoke Reduces the Efficacy of Cisplatin in Head and Neck Cancer Cells - Role of ABCG2.
    Simon F; Schwenk-Zieger S; Becker S; Unger K; Gires O; Baumeister P
    Anticancer Res; 2020 Mar; 40(3):1277-1284. PubMed ID: 32132024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in Head and Neck Cancer Cells.
    Sadhasivam B; Manyanga J; Ganapathy V; Acharya P; Bouharati C; Chinnaiyan M; Mehta T; Mathews B; Castles S; Rubenstein DA; Tackett AP; Zhao YD; Ramachandran I; Queimado L
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
    Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
    J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer.
    Hsu DS; Lan HY; Huang CH; Tai SK; Chang SY; Tsai TL; Chang CC; Tzeng CH; Wu KJ; Kao JY; Yang MH
    Clin Cancer Res; 2010 Sep; 16(18):4561-71. PubMed ID: 20823140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
    Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B
    J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.
    Zhang M; Mathur A; Zhang Y; Xi S; Atay S; Hong JA; Datrice N; Upham T; Kemp CD; Ripley RT; Wiegand G; Avital I; Fetsch P; Mani H; Zlott D; Robey R; Bates SE; Li X; Rao M; Schrump DS
    Cancer Res; 2012 Aug; 72(16):4178-92. PubMed ID: 22751465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance.
    Chang X; Ravi R; Pham V; Bedi A; Chatterjee A; Sidransky D
    PLoS One; 2011; 6(6):e20806. PubMed ID: 21698293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab.
    Niehr F; Weichert W; Stenzinger A; Budach V; Tinhofer I
    J Transl Med; 2015 Apr; 13():106. PubMed ID: 25890004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
    Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K
    Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of ABCG2 in head and neck squamous cell carcinoma and cell lines.
    Shen B; Dong P; Li D; Gao S
    Exp Ther Med; 2011 Nov; 2(6):1151-1157. PubMed ID: 22977636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma.
    Ryumon S; Okui T; Kunisada Y; Kishimoto K; Shimo T; Hasegawa K; Ibaragi S; Akiyama K; Thu Ha NT; Monsur Hassan NM; Sasaki A
    Oncol Rep; 2019 Dec; 42(6):2611-2621. PubMed ID: 31638244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer.
    Friedman J; Nottingham L; Duggal P; Pernas FG; Yan B; Yang XP; Chen Z; Van Waes C
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6568-78. PubMed ID: 18006756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo.
    Köberle B; Ditz C; Kausch I; Wollenberg B; Ferris RL; Albers AE
    Int J Oncol; 2010 May; 36(5):1277-84. PubMed ID: 20372803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Level of Tobacco Carcinogen-Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers.
    Khariwala SS; Ma B; Ruszczak C; Carmella SG; Lindgren B; Hatsukami DK; Hecht SS; Stepanov I
    Cancer Prev Res (Phila); 2017 Sep; 10(9):507-513. PubMed ID: 28679497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoke condensate promotes pro-tumourigenic stromal-epithelial interactions by suppressing miR-145.
    Pal A; Melling G; Hinsley EE; Kabir TD; Colley HE; Murdoch C; Lambert DW
    J Oral Pathol Med; 2013 Apr; 42(4):309-14. PubMed ID: 23173553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines.
    Lee SK; Kim SB; Kim JS; Moon CH; Han MS; Lee BJ; Chung DK; Min YJ; Park JH; Choi DH; Cho HR; Park SK; Park JW
    Int J Cancer; 2005 Oct; 117(1):32-40. PubMed ID: 15880358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.